Coronavirus Disease 2019 (COVID-19) Poses Challenges for the U.S. Blood Supply [March 13, 2020] [open pdf - 522KB]
From the Document: "The current Coronavirus Disease 2019 (COVID-19) outbreak may pose significant challenges for the United States' blood supply. Mitigation strategies to prevent the spread of COVID-19, such as closures of schools and workplaces, have led to blood drive cancellations, resulting in a critical blood supply shortage in the Pacific Northwest (specifically, western Washington and Oregon). School closures, event cancellations, and other mitigation strategies in other areas of the country may provide challenges for maintaining a sufficient blood supply. The management and distribution of the U.S. blood supply is largely coordinated by private organizations, with some oversight by the Department of Health and Human Services (HHS). Congress may consider how best to address critical storages, such as through HHS or the U.S. Food and Drug Administration's (FDA) authority over blood safety and donation guidance."
CRS Insight, IN11238
Congressional Research Service: https://crsreports.congress.gov/